Pharmaceuticals
Eisai-Biogen Alzheimer's drug backed for full U.S. approval
FDA decision on Leqembi expected by July 6
Pharmaceuticals
Pharmaceuticals
Chinese robotic assisted surgery system challenges U.S.'s da Vinci
'Made in China' push could help national champions claw away at industry giant
Pharmaceuticals
Eisai eyes low-cost supplies of Alzheimer's drug in SE Asia, India
Sustainable loans considered for FDA-approved lecanemab
Pharmaceuticals
Lab monkey prices soar in U.S. after China cuts off exports
Hunt for new supplier continues as Beijing keeps research animals on short leash
Business deals
Japan's Astellas to buy U.S.-based Iveric Bio for $5.9bn
Cross-border acquisition would be 2nd-biggest in 5 years by a Japanese drugmaker
Pharmaceuticals
Japan health ministry panel OKs oral abortion pill for 1st time
Drug contains mifepristone, which blocks a pregnancy hormone
COVID vaccines
Moderna eyes local COVID vaccines for Japan, other countries
Chief Medical Officer Paul Burton highlights room for region-specific shots
Pharmaceuticals
Mitsui & Co. invests in Singapore pharma marketer Wellesta
Trading house sees growth in Asia for drugs already approved in developed world
COVID vaccines
China approves first homegrown mRNA vaccine, says drugmaker CSPC
Jabs target omicron variants, with 85.3% efficacy from two weeks after booster
Technology
Japan drug and chemical makers tap AI for faster development
Astellas, Eisai and Asahi Kasei follow U.S. lead on lab automation
Business Spotlight
Indonesia and its ASEAN neighbors take to telemedicine
Growing populations, fewer physicians spur apps like Alodokter, Doctor Anywhere
Interview
Kobayashi Pharma to tap Southeast Asian demand with new plant: COO
Japanese drugmaker hopes to hedge risks by producing and selling locally
Datawatch
Diabetes ravages emerging nations in Asia, Africa
Number of patients projected to jump 50% by 2045 as dietary habits change
COVID vaccines
Japan's 1st plant for mRNA COVID vaccine to be built by Daiichi Sankyo
Drugmaker targets capacity of 20m doses yearly, boosting nation's preparedness
Opinion
Time for India to be firm with drugmakers rather than deregulate
Lax stance risks opportunity for 'friend-shoring' to serve Western nations
Pharmaceuticals
Japan's 1st abortion pill takes step closer to approval
Treatment would give women option other than surgical procedure
Pharmaceuticals
WHO urges 'immediate action' after cough syrup deaths
Contaminated over-the-counter medicines killed 300-plus children in 2022
Pharmaceuticals
Eisai's new Alzheimer's drug divides market watchers
Leqembi's price point spurs optimism after Aduhelm, but wide use unclear
Datawatch
COVID disrupts measles and other vaccinations in Asia, elsewhere
Pandemic saps resources to protect infants from contagious diseases
DealStreetAsia
Sequoia China-backed biopharma company files for $100m U.S. IPO
Structure Therapeutics developing drugs targeting a wide range of chronic diseases
